FR2282908B1 - - Google Patents

Info

Publication number
FR2282908B1
FR2282908B1 FR7526861A FR7526861A FR2282908B1 FR 2282908 B1 FR2282908 B1 FR 2282908B1 FR 7526861 A FR7526861 A FR 7526861A FR 7526861 A FR7526861 A FR 7526861A FR 2282908 B1 FR2282908 B1 FR 2282908B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7526861A
Other languages
French (fr)
Other versions
FR2282908A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Canadian Patents and Development Ltd
Original Assignee
Canadian Patents and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canadian Patents and Development Ltd filed Critical Canadian Patents and Development Ltd
Publication of FR2282908A1 publication Critical patent/FR2282908A1/fr
Application granted granted Critical
Publication of FR2282908B1 publication Critical patent/FR2282908B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7526861A 1974-09-02 1975-09-02 Vaccin contre la colibacillose Granted FR2282908A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3827974A GB1472624A (en) 1974-09-02 1974-09-02 Enteric disease vaccine

Publications (2)

Publication Number Publication Date
FR2282908A1 FR2282908A1 (fr) 1976-03-26
FR2282908B1 true FR2282908B1 (Direct) 1978-11-10

Family

ID=10402419

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7526861A Granted FR2282908A1 (fr) 1974-09-02 1975-09-02 Vaccin contre la colibacillose

Country Status (9)

Country Link
JP (1) JPS5151514A (Direct)
AU (1) AU8440975A (Direct)
BE (1) BE832967A (Direct)
DE (1) DE2538994A1 (Direct)
DK (1) DK386875A (Direct)
FR (1) FR2282908A1 (Direct)
GB (1) GB1472624A (Direct)
NL (1) NL7510120A (Direct)
ZA (1) ZA755043B (Direct)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466251B1 (fr) * 1979-10-03 1983-03-18 Agronomique Inst Nat Rech Vaccin animal anticolibacillaire, obtention et application
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
AU559550B2 (en) * 1981-03-09 1987-03-12 Cetus Corporation Vaccines
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
CA1338705C (en) * 1981-10-22 1996-11-12 Roy Curtiss Iii Vaccines obtained from antigenic gene products of recombinant genes
US4971794A (en) * 1982-09-02 1990-11-20 Unilever Patent Holdings B.V. Production of antibodies using a mixture of strains of E. coli collectively expressing type I pili, CFA I pili, CFA II pili and K88 pili
NZ205392A (en) * 1982-09-02 1987-03-06 Unilever Plc Preparation of immunoglobulins against e.coli pili
WO1985003521A1 (en) * 1984-02-01 1985-08-15 Enterovax Research Pty. Ltd. Bacterial strains
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE9100556D0 (sv) * 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
EP0659086B1 (en) * 1992-09-04 1998-11-11 The University of Saskatchewan Novel bacterial vaccines using vaccine strains of pathogenic bacteria

Also Published As

Publication number Publication date
DE2538994A1 (de) 1976-06-16
JPS5151514A (en) 1976-05-07
ZA755043B (en) 1976-06-30
BE832967A (fr) 1975-12-31
FR2282908A1 (fr) 1976-03-26
AU8440975A (en) 1977-03-03
DK386875A (da) 1976-03-03
GB1472624A (en) 1977-05-04
NL7510120A (nl) 1976-03-04

Similar Documents

Publication Publication Date Title
FR2282908B1 (Direct)
AU495870B2 (Direct)
AU7465874A (Direct)
AU7138274A (Direct)
AU7034374A (Direct)
AU6599874A (Direct)
BG19488A1 (Direct)
BG19639A1 (Direct)
BG19736A1 (Direct)
AU481544A (Direct)
AU481915A (Direct)
AU481917A (Direct)
AU481934A (Direct)
AU482332A (Direct)
AU481001A (Direct)
AU480902A (Direct)
AU480348A (Direct)
AU480063A (Direct)
AU479777A (Direct)
BE827400A (Direct)
BE829575A (Direct)
BE829576A (Direct)
BE836576A (Direct)
BG19760A1 (Direct)
BG19624A1 (Direct)

Legal Events

Date Code Title Description
ST Notification of lapse